• Metabolomics Reveals Resistant Phenotype in CPE via LC-MS/MS

  2026-04-21

  This study applies LC-MS/MS metabolomics to profile carbapenemase-producing Enterobacterales (CPE), identifying 21 metabolite biomarkers that robustly discriminate resistant from non-resistant isolates in under 7 hours. These findings offer a pathway to rapid diagnostics and mechanistic insights, with implications for antibiotic resistance studies and the future of clinical microbiology.

• Atropo-Enantioselective Suzuki Coupling Yields Potent Antimi

  2026-04-20

  This study introduces a catalytic asymmetric synthesis of axially chiral biaryl compounds with antimitotic activity, using an atropo-enantioselective Suzuki cross-coupling. The approach enables precise control over axial chirality, unlocking access to structural analogues of natural antimitotic agents and informing future design of selective inhibitors relevant to cancer and metabolic research.

• IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan

  2026-04-20

  This study identifies IGF2BP3 as a dominant m6A reader that stabilizes FZD1/7 mRNAs, promoting cancer stem cell maintenance and carboplatin resistance in triple-negative breast cancer (TNBC). The mechanistic insights into the IGF2BP3–FZD1/7–β-catenin pathway suggest new therapeutic strategies to overcome chemoresistance in TNBC.

• Macrophage EV miR-660 Drives Breast Cancer via KLHL21/NF-κB

  2026-04-19

  This article examines how tumor-associated macrophage (TAM)-derived extracellular vesicles (EVs) containing microRNA-660 (miR-660) promote breast cancer metastasis by targeting the KLHL21/IKKβ/NF-κB p65 signaling axis. The findings highlight a complex intercellular communication mechanism that drives tumor progression and suggest novel molecular targets for intervention.

• (-)-Arctigenin as a Next-Gen MEK1 Inhibitor in Tumor Immunol

  2026-04-18

  Explore how (-)-Arctigenin, a potent MEK1 inhibitor and iNOS expression inhibitor, uniquely empowers translational researchers to dissect and modulate NF-κB-driven tumor microenvironments, particularly in breast cancer models. This article blends mechanistic insight with actionable guidance, drawing on cutting-edge evidence and the APExBIO product platform.

• SM-164: Bivalent Smac Mimetic for High-Fidelity Apoptosis St

  2026-04-17

  SM-164 enables rapid, reproducible apoptosis induction in tumor models through potent IAP antagonism, outperforming conventional mimetics in both speed and specificity. This guide delivers hands-on workflow strategies, protocol optimizations, and troubleshooting tactics to unlock the full experimental power of SM-164 in advanced cancer research.

• LMO2–LDB1 Complex Drives AML Progression: Mechanistic Insigh

  2026-04-16

  This study demonstrates that the LMO2 transcriptional regulator, through interaction with the co-regulator LDB1, is a key driver of proliferation and survival in acute myeloid leukemia (AML) cell lines. The mechanistic dissection of this complex provides actionable insight into potential therapeutic targets and highlights the molecular underpinnings of AML maintenance and progression.

• L-Alanyl-L-Glutamine: Molecular Precision for Intestinal Bar

  2026-04-15

  Explore the molecular mechanisms by which L-Alanyl-L-glutamine enhances intestinal barrier function and supports antioxidant and anti-inflammatory defenses. This article offers a unique, assay-focused perspective on the L-Ala-L-Gln dipeptide, setting it apart from existing content.

• Protein A/G Magnetic Beads: Precision Tools for Protein Inte

  2026-04-14

  Unlock reproducible, low-background protein interaction studies with Protein A/G Magnetic Beads—combining dual-specificity and minimal non-specific binding. Explore advanced workflows and troubleshooting strategies inspired by recent breakthroughs in intervertebral disc degeneration research.

• Protein A/G Magnetic Beads: Driving Next-Gen Cancer Stem Cel

  2026-04-13

  Explore how Protein A/G Magnetic Beads enable precise antibody purification and advanced protein-protein interaction analysis in cancer stem cell research. This article reveals their unique advantages for dissecting resistance mechanisms in triple-negative breast cancer.

• Dual-Action p38α Inhibitors Accelerate Dephosphorylation: Me

  2026-04-12

  This study reveals that certain kinase inhibitors, including those structurally related to Losmapimod, drive a unique dual action on p38α MAP kinase by not only blocking its activity but also accelerating its dephosphorylation by WIP1 phosphatase. These findings establish a new mechanistic paradigm for enhancing inhibitor potency and selectivity in inflammation and vascular research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-04-12

  This study provides a detailed genomic and epidemiological analysis of carbapenemase-encoding gene (CEG) transmission in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong Province, China, from 2022–2024. Its findings reveal high rates of plasmid-mediated blaNDM-1 dissemination and multidrug resistance, offering critical insights for researchers studying mechanisms of resistance and intervention strategies.

• Protein A/G Magnetic Beads: Practical Guidance for Immunopre

  2026-04-11

  Protein A/G Magnetic Beads (SKU K1305) address the need for efficient, low-background antibody purification and immunoprecipitation from complex biological matrices. This product is best suited for workflows requiring high specificity in IgG binding and reduced non-specific interactions, but should not be used for diagnostic or clinical purposes due to its research-only designation.

• Aconitase Activity Colorimetric Assay Kit: Precision for TCA

  2026-04-11

  Unlock advanced, high-throughput quantification of iron-sulfur protein aconitase activity with the Aconitase Activity Colorimetric Assay Kit. This platform empowers researchers to dissect mitochondrial function, oxidative damage, and metabolic flexibility with rapid, robust colorimetric detection.

• Verbascoside: Precision PKC/NF-κB Inhibitor for Osteoclas...

  2026-04-10

  Verbascoside from APExBIO offers unparalleled reproducibility and specificity as a PKC/NF-κB inhibitor, streamlining osteoclastogenesis and inflammation research. This guide delivers actionable workflows, troubleshooting strategies, and advanced use-cases, empowering investigators to drive impactful discoveries in bone metabolism and chronic inflammatory disease.

16232 records 1/1083 page Next 12345 下5页 Last page